More than 37,000 Americans diagnosed with pancreatic cancer this year, and 75 % die within the first 12 months after diagnosis. Pancreatic cancer is the fourth leading cause of cancer death in the United States, nor any of the under-funded for research.
This this urgent need to be, PanCAN call support a minimum support a minimum 6.7 % for the National Institutes of Health and the National Cancer Institute . In 2006, an estimated $ 66,000 dollars from the NCI cancer research investment on pancreatic cancer on pancreatic cancer research. This was just one per cent of the NCI $ $ 4800000000 cancer research budget for 2006.. For research. Cancer Action Network urges Congress more resources to this deadly disease ExpertToday Pancreatic Cancer Action Network and 165 lawyers from across the United States in Washington, DC to call on members of Congress support federal cancer research funding.Of this obligation in terms of a deep understanding and predictive models, algorithm and bioinformatics tools, as well as unique R & D team, have created the basis on development and use a growing stock the discovery of platform as shown, drawn through these and other date announcements, it now to fast growing intellectual property portfolio of medicines and diagnostic product candidate that. ‘.. The cooperation contract with Teva is, announced in January 2007, granted to Teva is one license for all discovered marker house of research and development using.
About Compugen nucleic acid testing Discovery PlatformThis platform based on Compugen leads and MED infrastructure platforms and extra public and proprietary sources. Various algorithms and statistical and machine learning tools can be of the discovery of novel RNA transcripts of as as a diagnostic biomarker. A platform has been developed to enable the discovery of singles and multiple combination biomarkers and expected to be used widely for discovering such biomarkers of toxicity and on certain diseases biomarker discovery, like for a variety epithelial tumors of and atherosclerosis.